Poonawalla: The Poonawalla family donates 500 million. Rs to Oxford University to build new vaccine research center – Times of India

LONDON: The owners of Serum Institute of India, the Poonawalla family, has announced a donation of £ 50 million (Rs 500 billion) to Oxford University to build a new research center focusing on vaccinology.
The donation from Serum Life Sciences, 100% owned by the Poonawalla family, is Oxford the university’s greatest gift ever for vaccine research. It will be used to create a new facility to house more than 300 researchers on the Old Road Campus.
The name Poonawalla Vaccines Research Building will house the headquarters and primary laboratory area of ​​the Jenner Institute, where the Oxford University / AstraZeneca Covid-19 vaccine was developed, as well as other leading Oxford teams, such as those developing a malaria vaccine.
It will be built on the same site as the recently announced Oxford University Pandemic Sciences Center, and the two buildings will share infrastructure and support facilities for scientific research and academic teaching and together will form a unique hub that will contribute to global pandemic preparedness.
Professor Louise Richardson, Vice-Chancellor of Oxford University, said: “The University has many years of ties with the Poonawalla family and we were delighted to be able to award an honorary degree to Cyrus Poonawalla in the summer of 2019 in recognition of his extraordinary work in producing inexpensive vaccines for “I am glad that through this generous gift we will be able to advance our work with vaccines that have been shown to be so critical to global health.”
Future collaborations between the Serum Institute and the Jenner Institute include an agreement that the Serum Institute will mass-produce and develop the Jenner Institute’s promising malaria vaccine, which is currently in Phase III trials, and prioritizes countries with high malaria burdens.
Prof Adrian Hill, director of the Jenner Institute, said the success of the collaboration between the university and the Serum Institute on malaria and Covid-19 vaccines highlighted the potential of partnerships between universities and manufacturers to develop and deliver vaccines cost-effectively on a large scale.


Source link

Leave a Comment